Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19

por G. Moreira, Thais, Gauthier, Christian D., Murphy, Liam, Lanser, Toby B., Paul, Anu, Matos, Kimble T. F., Mangani, Davide, Izzy, Saef, Rezende, Rafael M., Healy, Brian C., Baecher-Allan, Clare M., Chitnis, Tanuja, Kuchroo, Vijay, Weiner, Howard L.
Publicado 2023